Xconomy Boston

Satori Pharmaceuticals, Inc. Garners $22,000,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a3eda3b6-367b-49f5-bff6-665723e398bd&Preview=1
Date
1/8/2009
Company Name
Satori Pharmaceuticals, Inc.
Mailing Address
222 Berkeley Street Boston, MA 02116
Company Description
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders.
Website
http://www.satoripharma.com
Transaction Type
Venture Equity
Transaction Amount
$22,000,000
Transaction Round
Series B
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
InterWest Partners
Venture Investor
Prospect Venture Partners
Venture Investor
New Enterprise Associates
Venture Investor
PureTech Ventures